No insider purchase over the last 90 days. The latest was filed 06 Jul 2026.
This page follows insider dealings at CG Invites Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. Between 18 October 2025 and 18 October 2026, 8 insiders published 14 filings.
On the market, 7 insiders bought (11 purchases totalling €613k) while 1 insider sold (1 sale). No amount is published for 10 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €426k by 인바이츠지노믹스, published on 13 May 2026. On the buying side, the filings list 1 major shareholder among the declarants.
The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 87 days ago, on 23 July 2026.
Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 14 filings, this issuer sits above that mark. Our records for CG Invites Co., Ltd. go back to 2021, with 60 purchases and 26 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
+5 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 101 declarations
CG인바이츠 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.